Bayesian Capital Management’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

Bayesian Capital Management’s Portfolio DCT Stock Details DCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,693	Closed	-$189K	–	1182
2022 Q4	$189K	Buy	+15,693	New	+$180K	0.03%	609
2022 Q3	–	Sell	-20,347	Closed	-$302K	–	1097
2022 Q2	$302K	Buy	+20,347	New	+$357K	0.06%	483
2022 Q1	–	Sell	-16,385	Closed	-$493K	–	962
2021 Q4	$493K	Buy	+16,385	New	+$527K	0.16%	176

Other funds holding DCT

FDx Advisors Chicago, Illinois $313M AUM 18.92% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bayesian Capital Management's DCT Position: Q1 2023 in Review

Bayesian Capital Management sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q1 2023, closing a stake of 15,693 shares — an estimated $189K sold.

Bayesian Capital Management first reported a position in DCT in Q4 2021 and held it in 3 quarters. The position peaked at $493K in Q4 2021. 4 funds tracked by Wall St. Rank hold DCT as of Q1 2023.

Bayesian Capital Management reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bayesian Capital Management sold 15,693 Duck Creek Technologies, Inc. Common Stock shares in Q1 2023, an estimated $189K.
Bayesian Capital Management first reported a position in Duck Creek Technologies, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Bayesian Capital Management's Duck Creek Technologies, Inc. Common Stock position peaked at $493K in Q4 2021.
4 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.